glp-1 for mcas MCAS: Addressing Gastroparesis Concerns Does anyone use GLP-1 and

This, in turn, results in the activation of the unfolded protein response (UPR), the endoplasmic reticulum overload response, and the caspase-12-mediated apoptosis pathway

Weight Loss While all GLP-1 receptor agonists were initially developed to manage type 2 diabetes, some, like Wegovy, are FDA-approved for weight loss

PMCID: PMC8818133

If you skip the 2mg phase entirely and start at 4mg (which some protocols allow), the gastrointestinal side effects are notably more severe, trading impatience now for discomfort later

Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B